MiR-506 targets polypyrimidine tract-binding protein 1 to inhibit airway inflammatory response and remodeling via mediating Wnt/β-catenin signaling pathwayYuxiang Cai, Xiaolan Shi|Allergologia et Immunopathologia|2023Cited by 4